229 related articles for article (PubMed ID: 30165235)
1. Dermal peptide delivery using enhancer molecules and colloidal carrier systems. Part III: Tetrapeptide GEKG.
Sommer E; Neubert RHH; Mentel M; Tuchscherer B; Mrestani Y; Wohlrab J
Eur J Pharm Sci; 2018 Nov; 124():137-144. PubMed ID: 30165235
[TBL] [Abstract][Full Text] [Related]
2. Dermal peptide delivery using enhancer moleculs and colloidal carrier systems. Part II: Tetrapeptide PKEK.
Neubert RHH; Sommer E; Schölzel M; Tuchscherer B; Mrestani Y; Wohlrab J
Eur J Pharm Biopharm; 2018 Mar; 124():28-33. PubMed ID: 29247690
[TBL] [Abstract][Full Text] [Related]
3. Dermal peptide delivery using enhancer molecules and colloidal carrier systems--part I: carnosine.
Goebel AS; Schmaus G; Neubert RH; Wohlrab J
Skin Pharmacol Physiol; 2012; 25(6):281-7. PubMed ID: 22890441
[TBL] [Abstract][Full Text] [Related]
4. Final report of the amended safety assessment of Glyceryl Laurate, Glyceryl Laurate SE, Glyceryl Laurate/Oleate, Glyceryl Adipate, Glyceryl Alginate, Glyceryl Arachidate, Glyceryl Arachidonate, Glyceryl Behenate, Glyceryl Caprate, Glyceryl Caprylate, Glyceryl Caprylate/Caprate, Glyceryl Citrate/Lactate/Linoleate/Oleate, Glyceryl Cocoate, Glyceryl Collagenate, Glyceryl Erucate, Glyceryl Hydrogenated Rosinate, Glyceryl Hydrogenated Soyate, Glyceryl Hydroxystearate, Glyceryl Isopalmitate, Glyceryl Isostearate, Glyceryl Isostearate/Myristate, Glyceryl Isostearates, Glyceryl Lanolate, Glyceryl Linoleate, Glyceryl Linolenate, Glyceryl Montanate, Glyceryl Myristate, Glyceryl Isotridecanoate/Stearate/Adipate, Glyceryl Oleate SE, Glyceryl Oleate/Elaidate, Glyceryl Palmitate, Glyceryl Palmitate/Stearate, Glyceryl Palmitoleate, Glyceryl Pentadecanoate, Glyceryl Polyacrylate, Glyceryl Rosinate, Glyceryl Sesquioleate, Glyceryl/Sorbitol Oleate/Hydroxystearate, Glyceryl Stearate/Acetate, Glyceryl Stearate/Maleate, Glyceryl Tallowate, Glyceryl Thiopropionate, and Glyceryl Undecylenate.
Int J Toxicol; 2004; 23 Suppl 2():55-94. PubMed ID: 15513825
[TBL] [Abstract][Full Text] [Related]
5. Investigation of microemulsion and microemulsion gel formulations for dermal delivery of clotrimazole.
Zhang J; Michniak-Kohn BB
Int J Pharm; 2018 Jan; 536(1):345-352. PubMed ID: 29170117
[TBL] [Abstract][Full Text] [Related]
6. Microemulsions as transdermal drug delivery vehicles.
Kogan A; Garti N
Adv Colloid Interface Sci; 2006 Nov; 123-126():369-85. PubMed ID: 16843424
[TBL] [Abstract][Full Text] [Related]
7. Investigation of ex vivo Skin Penetration of Coenzyme Q10 from Microemulsions and Hydrophilic Cream.
Tessema EN; Bosse K; Wohlrab J; Mrestani Y; Neubert RHH
Skin Pharmacol Physiol; 2020; 33(6):293-299. PubMed ID: 33212439
[TBL] [Abstract][Full Text] [Related]
8. Dermal peptide delivery using colloidal carrier systems.
Goebel A; Neubert RH
Skin Pharmacol Physiol; 2008; 21(1):3-9. PubMed ID: 17912018
[TBL] [Abstract][Full Text] [Related]
9. Development and skin penetration pathway evaluation of microemulsions for enhancing the dermal delivery of celecoxib.
Subongkot T; Sirirak T
Colloids Surf B Biointerfaces; 2020 Sep; 193():111103. PubMed ID: 32438237
[TBL] [Abstract][Full Text] [Related]
10. Dermal delivery of desmopressin acetate using colloidal carrier systems.
Getie M; Wohlrab J; Neubert RH
J Pharm Pharmacol; 2005 Apr; 57(4):423-7. PubMed ID: 15831201
[TBL] [Abstract][Full Text] [Related]
11. Dermal targeting using colloidal carrier systems with linoleic acid.
Goebel AS; Knie U; Abels C; Wohlrab J; Neubert RH
Eur J Pharm Biopharm; 2010 Jun; 75(2):162-72. PubMed ID: 20170728
[TBL] [Abstract][Full Text] [Related]
12. Dermal peptide delivery using enhancer molecules and colloidal carrier systems - part V
Foerster A; Neubert RHH
Pharmazie; 2019 Mar; 74(3):136-141. PubMed ID: 30961677
[TBL] [Abstract][Full Text] [Related]
13. New microemulsion vehicle facilitates percutaneous penetration in vitro and cutaneous drug bioavailability in vivo.
Sintov AC; Shapiro L
J Control Release; 2004 Mar; 95(2):173-83. PubMed ID: 14980766
[TBL] [Abstract][Full Text] [Related]
14. Percutaneous delivery of econazole using microemulsion as vehicle: formulation, evaluation and vesicle-skin interaction.
Ge S; Lin Y; Lu H; Li Q; He J; Chen B; Wu C; Xu Y
Int J Pharm; 2014 Apr; 465(1-2):120-31. PubMed ID: 24530389
[TBL] [Abstract][Full Text] [Related]
15. Protein transduction domain-containing microemulsions as cutaneous delivery systems for an anticancer agent.
Pepe D; McCall M; Zheng H; Lopes LB
J Pharm Sci; 2013 May; 102(5):1476-87. PubMed ID: 23436680
[TBL] [Abstract][Full Text] [Related]
16. Microemulsions as colloidal vehicle systems for dermal drug delivery. Part V: Microemulsions without and with glycolipid as penetration enhancer.
Neubert RH; Schmalfuss U; Wolf R; Wohlrab WA
J Pharm Sci; 2005 Apr; 94(4):821-7. PubMed ID: 15736192
[TBL] [Abstract][Full Text] [Related]
17. Topical delivery of acetyl hexapeptide-8 from different emulsions: influence of emulsion composition and internal structure.
Hoppel M; Reznicek G; Kählig H; Kotisch H; Resch GP; Valenta C
Eur J Pharm Sci; 2015 Feb; 68():27-35. PubMed ID: 25497319
[TBL] [Abstract][Full Text] [Related]
18. Development of drug delivery systems for the dermal application of therapeutic DNAzymes.
Schmidts T; Marquardt K; Schlupp P; Dobler D; Heinz F; Mäder U; Garn H; Renz H; Zeitvogel J; Werfel T; Runkel F
Int J Pharm; 2012 Jul; 431(1-2):61-9. PubMed ID: 22531847
[TBL] [Abstract][Full Text] [Related]
19. Colloidal nanocarriers for the enhanced cutaneous delivery of naftifine: characterization studies and in vitro and in vivo evaluations.
Erdal MS; Özhan G; Mat MC; Özsoy Y; Güngör S
Int J Nanomedicine; 2016; 11():1027-37. PubMed ID: 27042058
[TBL] [Abstract][Full Text] [Related]
20. Dermal and transdermal peptide delivery using enhancer molecules and colloidal carrier systems. Part V: Transdermal administration of insulin.
Alyoussef Alkrad J; Neubert RHH
Int J Pharm; 2022 Mar; 616():121511. PubMed ID: 35091007
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]